Efficacy and safety of a quail egg homogenate-based dietary supplement as adjunctive therapy in patients with seasonal allergic rhinitis

Not Applicable

• Conditions: J30.1; Allergic rhinitis due to pollen

• Registration Number: DRKS00023981
• Lead Sponsor: niversity of Catania

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-09-03
• Study Start: 2020-12-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients were eligible to participate if the following inclusion criteria were met:
- age =18 years old;
- recent diagnosis/clinically relevant history of mild to severe SAR to the most common inhalant allergens prevalent in the geographic area in which the study was carried out;
- who did not receive any treatment for SAR.

Exclusion Criteria

Patients were excluded from the study if they had any medical condition, such as pregnancy, a respiratory tract infection that could influence the study; uncontrolled asthma; taking an antihistamine, leukotriene receptor antagonist, and decongestant within the week before the study participation; consumption of corticosteroids within the month before the study participation; or known sensitivities to any of the ingredients of the study product.

Study & Design

• Study Type: interventional
• Study Design: Not specified